1
/
of
0
FDA Drug Approval, A211785, BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
FDA Drug Approval, A211785, BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
ANDA: 211785
Company: MYLAN TECHNOLOGIES
Drug Name: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Active Ingredients: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Strength: EQ 4MG BASE;EQ 1MG BASE
Dosage Form/Route: FILM;BUCCAL, SUBLINGUAL
Action Date: 04/17/2020
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Company: MYLAN TECHNOLOGIES
Drug Name: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Active Ingredients: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Strength: EQ 4MG BASE;EQ 1MG BASE
Dosage Form/Route: FILM;BUCCAL, SUBLINGUAL
Action Date: 04/17/2020
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details